AI brief of an SEC Form 8-K · Frazier Life Sciences Acquisition Corp. II (FLSC)

Frazier Life Sciences Acquisition Corp. II closes $75 million IPO

Neutral Impact 3 of 5 financing Written later

Frazier Life Sciences Acquisition Corp. II, a special purpose acquisition company, closed its initial public offering of 7,500,000 Class A ordinary shares at $10.00 per share on October 15, 2026, raising $75 million in gross proceeds. The company also sold 300,000 private placement shares to its sponsor for $3 million, and $75 million of the proceeds was placed in a trust account for public shareholders, who can only access it through a business combination or redemption, with a 24-month deadline from the IPO closing.

Key points

  • IPO of 7,500,000 Class A ordinary shares at $10.00 per share closed October 15, 2026, for gross proceeds of $75 million; shares trade on Nasdaq Capital Market under FLSC
  • Sponsor Frazier Life Sciences Holdings II, LLC bought 300,000 private placement shares at $10.00 each, for $3 million
  • $75 million placed in trust account held by Continental Stock Transfer & Trust Company; company has 24 months from IPO closing to complete an initial business combination
  • Frazier Life Sciences Public Fund, L.P. committed to buy at least 2,500,000 Class A shares at $10.00 each, a minimum of $25 million, at the closing of a business combination

The filing

CompanyFrazier Life Sciences Acquisition Corp. II (FLSC)
Form8-K, current report
Filed with the SECOct 15, 2026, 4:23 PM ET
Accession number0001193125-26-422919

Items reported: 1.01 Material Definitive Agreement3.02 Unregistered Equity Sale5.03 Bylaw / Charter Amendment8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:48 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 15, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.